Prosecution Insights
Last updated: July 17, 2026

BARUCH S. BLUMBERG INSTITUTE

3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days

Portfolio Summary

3
Total Pending OAs
2
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
2
Medium (67%)
1
Easy (33%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only1 (33%)
§112 only1 (33%)
Double-patenting + other1 (33%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

3
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

30 h
Manual time on pending OAs
6 h
Time saved (low, 20%)
10 h
Time saved (mid, 35%)
0.3 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
HOWELL, THEODORE R 1 66.7% +25.5%
ROMERO, KRISTEN WANG 1 71.4% +29.4%
BURKETT, DANIEL JOHN 1 64.4% +28.0%

Interview Candidates (3)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
18287988 METHODS, KITS AND COMPOSITIONS FOR REDUCING CHROMOSOMAL INSTABILITY IN CANCER CELLS HOWELL, THEODORE R
18285622 NOVEL HEPATOSELECTIVE POLYADENYLATING POLYMERASES INHIBITORS AND THEIR METHOD OF USE ROMERO, KRISTEN WANG
17920663 Compounds and Compositions for Treating Hematologic Malignancies BURKETT, DANIEL JOHN

Top Art Units

Art UnitApps
1628 1
1624 1
1600 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18287988 METHODS, KITS AND COMPOSITIONS FOR REDUCING CHROMOSOMAL INSTABILITY IN CANCER CELLS HOWELL, THEODORE R 1628 §103 Non-Final OA Pending Oct 23, 2023
18285622 NOVEL HEPATOSELECTIVE POLYADENYLATING POLYMERASES INHIBITORS AND THEIR METHOD OF USE ROMERO, KRISTEN WANG 1624 DPOther Non-Final OA Pending Oct 04, 2023
17920663 Compounds and Compositions for Treating Hematologic Malignancies BURKETT, DANIEL JOHN 1600 §112 Final Rejection Pending Oct 21, 2022

Managing BARUCH S. BLUMBERG INSTITUTE's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month